Reduced endplate currents underlie motor unit dysfunction in canine motor neuron disease

Journal of Neurophysiology

Volumn 88, Issue 6, 2002, Pages 3293-3304

  Rich, Mark M ^a   Waldeck, Robert F ^b   Cork, Linda C ^c   Balice Gordon, Rita J ^d   Fyffe, Robert E W ^e   Wang, Xueyong ^a   Cope, Timothy C ^a   Pinter, Martin J ^a  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b DREXEL UNIVERSITY COLLEGE OF MEDICINE   (United States)

^c STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d UNIVERSITY OF PENNSYLVANIA   (United States)

^e WRIGHT STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; AUTOSOMAL DOMINANT DISORDER; CONTROLLED STUDY; DOG; ENDPLATE POTENTIAL; HOMOZYGOTE; MOTONEURON; MOTOR NEURON DISEASE; MOTOR UNIT; MUSCLE CELL; NERVE CONDUCTION; NERVE STIMULATION; NEUROFILAMENT; NEUROMUSCULAR TRANSMISSION; NONHUMAN; PRIORITY JOURNAL; SPINAL MUSCULAR ATROPHY;

EID: 0036898592     PISSN: 00223077     EISSN: None     Source Type: Journal    
DOI: 10.1152/jn.00270.2002     Document Type: Article

References (49)

1. Alvarez FJ, Dewey DE, Harrington DA, and Fyffe RE. Cell-type specific organization of glycine receptor clusters in the mammalian spinal cord. J Comp Neurol 379: 150-170, 1997.
2. Argentieri TM, Aiken SP, Laxminarayan S, and McArdle JJ. Characteristics of synaptic transmission in reinnervating rat skeletal muscle. Eur J Physiol 421: 256-261, 1992.
3. Bagust J, Lewis DM, and Westerman RA. The properties of motor units in a fast and a sIow twitch muscle during post-natal development in the kitten. J Physiol (Lond) 237: 73-90, 1974.
4. Balice-Gordon RJ, Smith DB, Goldman J, Cork LC, Shirley A, Cope TC, and Pinter MJ. Functional motor unit failure precedes neuromuscular degeneration in canine motor neuron disease. Ann Neurol 47: 596-605, 2000.
5. Binder MD, Heckman CJ, and Powers RK. The physiological control of motoneuron activity. In: Handbook of Physiology. Exercise: Regulation and Integration of Multiple Systems. New York: Oxford, Am. Physiol. Soc., 1996, sect. 12, p. 3-53.
6. Burke RE. Motor units: Anatomy, physiology and functional organization. In: Handbook of Physiology. The Nervous System, Motor Control. Bethesda, MD: Am. Physiol. Soc., 1981, sect. 7, vol. II, Part 1, chapt. 10, p. 345-422.
7. Cope T and Pinter MJ. The size principle: Still working after all these years? News Physiol Sci 10: 280-286, 1995.
8. Cope TC and Clark BD. Motor-unit recruitment in the decerebrate cat: Several unit properties are equally good predictors of order. J Neurophysiol 66: 1127-1138, 1991.
9. Cork LC, Adams RJ, Griffin JW, and Price DL. Hereditary canine spinal muscular atrophy: A canine model of human motor neuron disease. In: Animal Models of Inherited Metabolic Diseases, edited by R. J. Desnick, D. F. Patterson, and D. G. Scarpelli. New York: Liss, 1982, p. 449-458.
10. Cork LC, Griffin JW, Choy C, Padula CA, and Price DL. Pathology of motor neurons in accelerated hereditary canine spinal muscular atrophy. Lab Invest 46: 89-99, 1982b.
11. Cork LC, Struble RG, Gold BG, Dicarlo C, Fahnestock KE, Griffin JW, and Price DL. Changes in the size of motor axons in hereditary canine spinal muscular atrophy. Lab Invest 61: 333-342, 1989.
12. Cork LC, Troncoso JC, Klavano GC, Johnson ES, Sternberger LA, Sternberger NH, and Price DL. Neurofilamentous abnormalities in motor neurons in spontaneously occuring animal disorders. J Neuropathol Exp Neurol 47: 420-431, 1988.
13. Dewaegh SM, Lee VM, and Brady S. Local modulation of neurofilament phosphorylation, axonal caliber, and slow axonal transport by myelinating Schwann cells. Cell 68: 451-463, 1992.
14. Frey D, Schneider C, Xu L, Borg J, Spooren W, and Caroni P. Early and selective loss of neuromuscular synapse subtypes with low sprouting competence in motorneuron diseases. J Neurosci 20: 2534-2542, 2000.
15. Gillingwater TH and Ribchester RR. Compartmental neurodegeneration and synaptic plasticity in the Wld(s) mutant mouse. J Physiol (Lond) 534: 627-639, 2001.
16. Guyton DL and Hambrecht FT. Theory and design of capacitor electrodes for chronic stimulation. Med Biol Eng September: 613-620, 1974.
17. Henning R and Lomo T. Firing patterns of motor units in normal rats. Nature 314: 164-166, 1985.
18. Hirano A. Cytopathology of Amyotrophic Lateral Sclerosis. New York: Raven Press, 1991.
19. Hoffman PN, Koo EH, Muma NA, Griffin JW, and Price DL. Role of neurofilaments in the control of axonal caliber in myelinated nerve fibers. In: Intrinsic Determinants of Neuronal Form and Function, edited by R. J. Lasek and M. M. Black. New York: Liss, 1988, p. 389-402.
20. Hsieh S-T, Kidd GJ, Crawford TO, Xu Z, Lin W-M, Trapp BD, Cleveland DW, and Griffin JW. Regional modulation of neurofilament organization by myelination in normal axons. J Neurosci 14: 6392-6401, 1994.
21. Julien J-P. A role for neurofilaments in the pathogenesis of amyotrophic lateral sclerosis. Biochem Cell Biol 73: 593-597, 1995.
22. Klivenyi P, Ferrante RJ, Matthews RT, Bogdanov MB, Klein AM, Andreassen OA, Mueller G, Wermer M, Kaddurah-Daouk R, and Beal MF. Neuroprotective effects of creatine in a transgenic animal model of amyotrophic lateral sclerosis. Nature Med 5: 347-350, 1999.
23. Lee AF and Bowen JM. Evaluation of motor nerve conduction velocity in the dog. Am J Vet Res 31: 1361-1366, 1970.
24. Li M, Ona VO, Guegan C, Chen M, Jackson-Lewis V, Andrews LJ, Olszewski AJ, Stieg PE, Lee J, Przedborski S, and Friedlander RM. Functional role of caspase-1 and caspase-3 in an ALS trangenic mouse model. Science 288: 335-339, 2000.
25. Magrassi L, Purves D, and Lichtman Jw. Fluorescent probes that stain living nerve terminals. J Neurosci 7: 1207-1214, 1987.
26. Maselli RA, Wollman RL, Leung C, Distad B, Palombi S, Richman DP, Salazar-Grueso EF, and Roos RP. Neuromuscular transmission in amyotrophic lateral sclerosis. Muscle Nerve 16: 1193-1203, 1993.
27. Mendell LM, Collins WF, and Munson JB. Retrograde determination of motoneuron properties and their synaptic input. J Neurobiol 25: 707-721, 1994.
28. Mitsumoto H, Chad DA, and Pioro EP. Amyotrophic Lateral Sclerosis. Philadelphia, PA: F A Davis, 1998.
29. Moore JW, Joyner RW, Brill MH, Waxman SD, and Najar-Joa M. Simulations of conduction in uniform myelinated fibers. Biophys J 21, 1978.
30. Muma NA and Cork LC. Alterations in neurofilament mRNA in hereditary canine spinal muscular atrophy. Lab Invest 69: 436-442, 1993.
31. Munson JB, Shelton DL, and McMahon SB. Adult mammalian sensory and motor neurons: Roles of endogenous neurotrophins and rescue by exogenous neurotrophins after axotomy. J Neurosci 17: 470-476, 1997.
32. Neter J, Wasserman W, and Kutner MH. Applied Linear Statistical Models. Boston, MA: Richard D. Irwin, 1990.
33. Pinter MJ. The role of motoneuron membrane properties in the determination of recruitment order. In: The Segmental Motor System, edited by M. D. Binder and L. M. Mendell. New York: Oxford, 1990, p. 165-181.
34. Pinter MJ, Cope T, Cork LC, Green SL, and Rich MM. Canine motor neuron disease: A view from the motor unit. In: Motor Neurobiology of the Spinal Cord, edited by T. C. Cope. Boca Raton, FL: CRC, 2001a, p. 231-250.
35. Pinter MJ, Cope TC, Shirley A, and Rich MM. Quantal content is reduced at neuromuscular junctions in hereditary canine spinal muscular atrophy. Soc Neurosci Meet 291, 2001b.
36. Pinter MJ and Vanden Noven S. Effects of preventing reinnervation on axotomized spinal motoneurons in the cat. I. Motoneuron electrical properties. J Neurophysiol 62: 311-324, 1989.
37. Pinter MJ, Vanden Noven S, Muccio D, and Wallace N. Axotomy-like changes of cat motoneuron electrical properties elicted by botulinum toxin depend on complete elimination of neuromuscular transmission. J Neurosci 11: 657-666, 1991.
38. Pinter MJ, Waldeck RF, Cope TC, and Cork LC. Effects of 4-aminopyridine on muscle and motor unit force in canine motor neuron disease. J Neurosci 17: 4500-4507, 1997.
39. Pinter MJ, Waldeck RF, Wallace N, and Cork LC. Motor unit behavior in canine motor neuron disease. J Neurosci 15: 3447-3457, 1995.
40. Rich MM and Lichtman JW. In vitro visualization of pre- and postsynaptic changes during synapse elimination in reinnervated mouse muscle. J Neurosci 9: 1781-1805, 1989.
41. Rich MM, Pinter MJ, Kraner SD, and Barchi RL. Loss of electrical excitability in an animal model of acute quadriplegic myopathy. Ann Neurol 43: 171-179, 1998.
42. Rich MM, Wang X, Cope TC, and Pinter MJ. Reduced neuromuscular quantal content with normal synaptic release time course and depression in canine motor neuron disease. J Neurophysiol 88: 3305-3314, 2002.
43. Rowland LP. Amyotrophic lateral sclerosis. Curr Opin Biol 7: 310-315, 1994.
44. Sagot Y, Dubois-Dauphin M, Tan SA, De Bilbao F, Aebischer P, Martinou J-C, and Kato AC. Bcl-2 overexpression prevents motoneuron cell body loss but not axonal degeneration in a mouse model of a neurodegenerative disease. J Neurosci 15: 7727-7733, 1995.
45. Sagot Y, Tan SA, Hammang JP, Aebischer P, and Kato AC. GDNF slows loss of motoneurons but not axonal degeneration or premature death of pmn/pmn mice. J Neurosci 16: 2335-2341, 1996.
46. Vanden Noven S and Pinter MJ. Effects of preventing reinnervation on axotomized spinal motoneurons in the cat. II. Changes in group Ia synaptic function. J Neurophysiol 62: 325-333, 1989.
47. Waxman. Determinants of conduction velocity in myelinated nerve fibers. Muscle Nerve 3: 141-150, 1980.
48. Williamson TL, Marszalek JH, Vechio JD, Bruijn LI, Lee MK, Xu Z, Brown RH, and Cleveland DW. Neurofilaments, radial growth of axons and mechanisms of motorneuron disease. Cold Spring Symp Quant Biol 61: 709-723, 1996.
49. Zajac FE. Coupling of recruitment order to the force produced by motor units: The "size principle hypothesis" revisited. In: The Segmental Motor System, edited by M. D. Binder and L. M. Mendell. New York: Oxford, 1990, p. 36-111.